Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated by Analysts at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a report issued on Saturday. The firm set a “hold” rating on the stock.

Separately, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $3.30 price objective on shares of Aspira Women’s Health in a research note on Wednesday, April 10th.

Aspira Women’s Health Trading Up 1.4 %

Shares of Aspira Women’s Health stock opened at $3.33 on Friday. The company has a market capitalization of $41.04 million, a PE ratio of -0.28 and a beta of 1.61. Aspira Women’s Health has a 12 month low of $2.31 and a 12 month high of $6.75. The stock’s fifty day simple moving average is $3.58 and its 200 day simple moving average is $4.00.

Aspira Women’s Health (NASDAQ:AWH) last issued its quarterly earnings data on Thursday, March 28th. The company reported ($0.30) EPS for the quarter, topping the consensus estimate of ($0.39) by $0.09. The business had revenue of $2.13 million for the quarter, compared to the consensus estimate of $2.70 million. Aspira Women’s Health had a negative return on equity of 1,099.32% and a negative net margin of 176.74%. Analysts predict that Aspira Women’s Health will post -1.24 EPS for the current fiscal year.

Institutional Trading of Aspira Women’s Health

Several hedge funds and other institutional investors have recently modified their holdings of AWH. B. Riley Wealth Advisors Inc. raised its stake in shares of Aspira Women’s Health by 43.1% in the 4th quarter. B. Riley Wealth Advisors Inc. now owns 179,371 shares of the company’s stock valued at $732,000 after purchasing an additional 53,997 shares during the period. Perkins Capital Management Inc. acquired a new stake in shares of Aspira Women’s Health in the 3rd quarter valued at about $268,000. Northeast Financial Consultants Inc acquired a new stake in shares of Aspira Women’s Health in the 3rd quarter valued at about $126,000. Finally, Quantum Private Wealth LLC raised its stake in shares of Aspira Women’s Health by 76.8% in the 4th quarter. Quantum Private Wealth LLC now owns 50,156 shares of the company’s stock valued at $205,000 after purchasing an additional 21,788 shares during the period. Institutional investors and hedge funds own 12.19% of the company’s stock.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.